Medical Condition News

RSS

Data can help scientists, physicians match precision drugs to cancer's genetic traits

More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.

13 Sep 2013

Four new pre-clinical drug development projects at NIH develop treatment for rare disease

Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.

13 Sep 2013

Loyola colorectal surgeon receives 2013 Robert M. Beart, MD, Impact Paper of the Year Award

Dana Hayden, MD, colorectal surgeon at Loyola University Health System accepted the 2013 Robert M. Beart, MD, Impact Paper of the Year Award from the American Society of Colon & Rectal Surgeons.

13 Sep 2013

UAB cardiovascular physician becomes first surgeon to use IntellaTip MiFi XP catheter in patient

University of Alabama at Birmingham cardiovascular physician Tom McElderry, M.D., has become the first surgeon in the United States to use the new IntellaTip MiFi™ XP catheter in a patient.

13 Sep 2013

GWCI awarded $2.1M cooperative agreement to support Comprehensive Cancer Control programs

The George Washington University Cancer Institute has been awarded a $2.1 million cooperative agreement to work with the Centers for Disease Control and Prevention to design and implement a comprehensive technical assistance plan to support CDC-funded Comprehensive Cancer Control programs.

13 Sep 2013

New behavioral therapy improves antidepressant treatment of OCD

NIMH grantees have demonstrated that a form of behavioral therapy can augment antidepressant treatment of obsessive compulsive disorder (OCD) better than an antipsychotic.

13 Sep 2013

Educational status may protect women living in socioeconomically disadvantaged areas against obesity

Educational status may protect women living in socioeconomically disadvantaged areas against obesity, finds a new study in the American Journal of Health Promotion.

13 Sep 2013

Simple method helps identify individuals who retain too much sodium

Getting a second urine sample and blood pressure measure as patients head out of the doctor's office appears an efficient way to identify those whose health may be in jeopardy because their bodies hold onto too much sodium, researchers report.

13 Sep 2013

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors.

13 Sep 2013

Study shows distinct molecular structures may predominate in brains of Alzheimer's patients

Alzheimer's disease is thought to be caused by the buildup of abnormal, thread-like protein deposits in the brain, but little is known about the molecular structures of these so-called beta-amyloid fibrils.

13 Sep 2013

Using large doses of codeine may heighten sensitivity to pain

Using large and frequent doses of the pain-killer codeine may actually produce heightened sensitivity to pain, without the same level of relief offered by morphine, according to new research from the University of Adelaide.

13 Sep 2013

Findings may help explain why some diabetic women prone to develop kidney failure

A genetic variant on chromosome 2 is strongly linked with kidney failure in diabetic women but not in men, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

13 Sep 2013

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

To prepare a potential new prostate cancer drug, called Gamitrinib, for trial in humans, The Wistar Institute has received a $1.5 million grant from the US Department of Defense's Congressionally Directed Medical Research Program.

13 Sep 2013

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Taking a page from Chinese herbal medicine, Scottsdale Healthcare and the Translational Genomics Research Institute today initiated the first-in-human clinical trial for pancreatic cancer patients using a compound derived from a plant known as "Thunder God vine."

13 Sep 2013

Brain atrophy leads to cognitive decline in T2DM people

New research has shown that cognitive decline in people with Type 2 Diabetes is likely due to brain atrophy, or shrinkage, that resembles patterns seen in the early stages of Alzheimer's disease.

13 Sep 2013

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis - the microbiological mechanisms have remained unclear.

13 Sep 2013

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

New research in mouse models suggests that treatment with antioxidants may help reduce behavioral issues linked to the genetic nervous system disorder Neurofibromatosis 1 (NF1) and an associated condition called Costello syndrome.

12 Sep 2013

Love Hormone May Play Role In Autism

...

12 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

New study to reduce unwanted side-effects of radiotherapy

Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.

From The University of Manchester 12 Sep 2013

Medical Condition News

Data can help scientists, physicians match precision drugs to cancer's genetic traits

Four new pre-clinical drug development projects at NIH develop treatment for rare disease

Loyola colorectal surgeon receives 2013 Robert M. Beart, MD, Impact Paper of the Year Award

UAB cardiovascular physician becomes first surgeon to use IntellaTip MiFi XP catheter in patient

GWCI awarded $2.1M cooperative agreement to support Comprehensive Cancer Control programs

New behavioral therapy improves antidepressant treatment of OCD

Educational status may protect women living in socioeconomically disadvantaged areas against obesity

Simple method helps identify individuals who retain too much sodium

Nanodiamonds deliver chemotherapy directly into brain tumors

Study shows distinct molecular structures may predominate in brains of Alzheimer's patients

Using large doses of codeine may heighten sensitivity to pain

Findings may help explain why some diabetic women prone to develop kidney failure

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Brain atrophy leads to cognitive decline in T2DM people

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

Love Hormone May Play Role In Autism

Omeros announces positive data from OMS824 Phase 1 clinical trial

New study to reduce unwanted side-effects of radiotherapy

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News